These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 10875793)

  • 1. Simple, practical ways to assess the protective efficacy of a new tuberculosis vaccine.
    Comstock GW
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S250-3. PubMed ID: 10875793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical issues in tuberculosis vaccine trials.
    Snider DE
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S271-5. PubMed ID: 10875798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research on BCG vaccination.
    ten Dam HG
    Adv Tuberc Res; 1984; 21():79-106. PubMed ID: 6433675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proposed national strategy for tuberculosis vaccine development.
    Ginsberg AM
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S233-42. PubMed ID: 10875790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The success and failure of BCG - implications for a novel tuberculosis vaccine.
    Andersen P; Doherty TM
    Nat Rev Microbiol; 2005 Aug; 3(8):656-62. PubMed ID: 16012514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us?
    Menzies D
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S71-4. PubMed ID: 11010826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical considerations in designing trials of vaccines for tuberculosis.
    Glassroth J
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S229-32. PubMed ID: 10875789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.
    Araujo Z; de Waard JH; de Larrea CF; Borges R; Convit J
    Vaccine; 2008 Oct; 26(44):5575-81. PubMed ID: 18723065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does BCG vaccination protect the newborn and young infants?
    ten Dam HG; Hitze KL
    Bull World Health Organ; 1980; 58(1):37-41. PubMed ID: 6991146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current tuberculosis vaccine development.
    Young DB
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S254-6. PubMed ID: 10875794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil.
    Barreto ML; Cunha SS; Pereira SM; Genser B; Hijjar MA; Yury Ichihara M; de Brito SC; Dourado I; Cruz A; Santa'Ana C; Rodrigues LC
    Int J Tuberc Lung Dis; 2005 Oct; 9(10):1171-3. PubMed ID: 16229231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of some hypotheses related to the Chingelput bacille Calmette-Guérin trial.
    Smith D; Wiegeshaus E; Balasubramanian V
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S77-80. PubMed ID: 11010828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in the effectiveness of Bacille Calmette-Guérin vaccine against pulmonary tuberculosis: a consequence of increased immune suppression by microbial antioxidants, not overattenuation.
    Kernodle DS
    Clin Infect Dis; 2010 Jul; 51(2):177-84. PubMed ID: 20524854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis vaccine.
    Sarhan MA
    Saudi Med J; 2010 Jan; 31(1):9-13. PubMed ID: 20062891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of vaccines to prevent childhood pneumonia: lessons relevant to planning tuberculosis vaccine trials.
    Mulholland K
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S206-9. PubMed ID: 10875784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving new vaccines for tuberculosis through the regulatory process.
    Brennan MJ
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S247-9. PubMed ID: 10875792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying experiences from trials of bacille Calmette-Guérin vaccine.
    Wilson ME
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S262-5. PubMed ID: 10875796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination against tuberculosis in humans, veterinary animals and wildlife species.
    Murphy D; Corner LA; Gormley E
    Tuberculosis (Edinb); 2008 Jul; 88(4):344-57. PubMed ID: 18222731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.